StockMarketWire.com - Health information technology group Akers Biosciences confirmed its shares would be canceled from trading on AIM.

The move was approved at a special meeting of shareholders held on Tuesday.

The last day of dealings in the company's common stock on AIM would be 28 March.


At 2:19pm: [LON:AKR] Akers Biosciences Inc share price was -17.5p at 70p



Story provided by StockMarketWire.com